Sou Hu Cai Jing·2026-01-13 03:14Group 1 - The A-share technology sector opened high but experienced a pullback, with the medical device ETF (562600) rising by 2.32% in early trading [1] - The medical device sector showed resilience, with notable stock performances: Di'an Diagnostics hitting the daily limit, BGI Genomics increasing by 14.41%, Hualan Biological by 8.01%, and Aide Biological by 5.41% [1] - The medical device ETF (562600) has seen significant capital inflow, with a net inflow of 140 million in the last five days and 162 million in the last ten days, reaching a trading volume of 30.68 million [1] Group 2 - The Shanghai government has announced the "Shanghai Brain-Machine Interface Future Industry Cultivation Action Plan (2025-2030)", aiming for clinical applications of invasive products by 2027 and full clinical application by 2030, establishing a global innovation hub [1] - The brain-machine interface industry is expected to benefit from policies such as the 14th Five-Year Plan, medical insurance coding, and medical device standards, with potential explosive growth in the global market [2] - The medical device ETF (562600) tracks the CSI All-Share Medical Device Index, with a 23.8% allocation to brain-machine interfaces, the highest among listed ETFs, effectively capturing growth opportunities in this niche [2]